Dottikon ES Holding AG

Dottikon ES Holding AG is a Swiss-based holding company that specializes in the manufacture of high-quality performance chemicals, intermediates, and exclusive active pharmaceutical ingredients (APIs) for the global chemical, biotech, and pharmaceutical industries. Operating primarily through its subsidiary Dottikon Exclusive Synthesis AG, the company positions itself as a strategic development and manufacturing partner, excelling in hazardous reactions, low-temperature and high-pressure chemistry, and continuous processing technologies. These capabilities enable innovative chemical processes that enhance yields, purities, and sustainability by reducing energy use, waste, and CO2 emissions. With roots tracing back to 1913 as a explosives specialist, Dottikon ES Holding AG went public on the SIX Swiss Exchange in 2005 following a spin-off from EMS-CHEMIE HOLDING AG. Its single-site facility in Dottikon, Switzerland, spans over 600,000 square meters, supporting rapid scale-up from kilograms to multi-tons with around 841 employees. The company maintains a strong focus on safety culture, compliance, and long-term customer relationships, with over 80% of net sales derived from APIs and revenues diversified across Europe, Switzerland, the US, and Asia.